Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out moreThe first Law Update of 2024 is here, and our first focus of the year spotlights Healthcare and Lifesciences, a sector that is undergoing significant growth and development across the MENA region.
Our focus provides an insight into some of the most important regulatory updates across the region, such as the UAE’s groundbreaking law on the use of human genome, Kuwait’s resolution on nuclear and radioactive materials, the new regulations for healthcare services in Qatar, Egypt’s healthcare regulatory framework, and the impact of the Saudi Civil Transactions Law on the healthcare and life sciences sector … and there is so much more!
Beyond the healthcare pages our lawyers share with you multi-sector insights where you will discover articles on Dubai’s DIFC regulatory framework for startups, Bahrain’s commercial agencies law, and we also shed light on Kuwaiti civil code and the advantages of setting up a joint stock company in Saudi Arabia.
Read the full editionOver the past 6 months healthcare regulatory authorities across the UAE have taken substantial action to ensure that all stakeholders in the healthcare sector, and all people that are residing in the United Arab Emirates (UAE), are working together to flatten the Coronavirus (COVID-19) curve in the country.
The Ministry of Health and Prevention (MoH), The Abu Dhabi Department of Health (DoH), The Dubai Health Authority (DHA) and The Dubai Healthcare City Authority (DHCA) have all enacted legislation, published circulars and drafted guidelines based on the recommendations of the World Health Organization (WHO), medical professionals and scientists.
Banks and Regulators in the UAE have also announced a series of relief measures for individuals and businesses to contain the economic consequences and aid those who have been impacted by the COVID-19 pandemic.
The most prominent of the measures prescribed by the respective healthcare regulatory authorities of the UAE over the past few months include:
These guidelines:
This circular was issued for the sake of the safety of patients participating in medical research and clinical trials in general, and in particular in research related to COVID-19 treatment. The DoH require that all health facilities adhere to the following:
These guidelines offer an explanation of the criteria and mechanisms for the implementation of measures to protect the residents of Dubai from the spread of COVID-19.
The business relief packages vary for those businesses within the DHCA which are termed as ‘Directly Impacted Segments’ and those which are termed as ‘Other Segments’;
Businesses within the ‘Directly Impacted’ segments include Community Outlets, Complementary and Alternative Medicine services, Continuing Education for Health Professionals, Cosmetics, Aesthetics, Dermatology and Plastic Surgery services, Dental services, Educational support services, Food & Beverage Outlets, Higher Education providers, Hotels, Ophthalmology services, Personal Care Centres, Schools, Support services, Technical & Occupational Skills and Wellness Studios;
Business that fall within the ‘Other Segments’ include pharmacies and supermarkets include convenience stores, grocery stores and mini stores.
Al Tamimi & Company’s specialist healthcare lawyers, regularly advise on legal and regulatory matters concerning the healthcare sector. For more details on our offering and how we can assist you, please contact us at healthcare@tamimi.com.
If you would like to have additional information on any of the topics covered above, or with other matters that are impacting your business with regard to COVID-19, please contact our special coronavirus email address: COVID-19advice@tamimi.com.
Andrea Tithecott
Partner, Head of Regulatory, Head of Healthcare
a.tithecott@tamimi.com
To learn more about our services and get the latest legal insights from across the Middle East and North Africa region, click on the link below.